VCAM1 and acute myeloid leukemia: These VLA-4/VCAM1-mediated interactions [204] promote AML cells’ chemoresistance by diverse mechanisms, including Bcl-2 overexpression [132] and JAK/STAT [259] and NF-κB signalling in MSCs.